Take for example, three men who showed up at a hospital in the northern part of India weak, feverish, and without any history of diabetes. They all tested positive for SARS-CoV-2. And when their bloodwork came back, they all had dangerously high buildups of glucose and ketones, which the body produces when it doesn’t have enough insulin to break down sugar. The official term for the potentially deadly complication is diabeteic ketoacidosis, and it is usually seen in children with type 1 diabetes.
Mohammad Shafi Kuchay, an endocrinologist who consulted on the cases, told WIRED via email that he and the other doctors assigned to the cases assumed the virus had somehow knocked out these patients’ insulin-making cells, giving them type 1 diabetes. And so the doctors put the men on a regimen of insulin injections. But as the months went by, they needed the injections less and less. They